Rituximab in myasthenia gravis: efficacy, associated infections and risk of induced hypogammaglobulinemia.
Neuromuscul Disord
; 32(8): 664-671, 2022 08.
Article
in En
| MEDLINE
| ID: mdl-35811274
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Agammaglobulinemia
/
Myasthenia Gravis
Type of study:
Etiology_studies
/
Guideline
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Neuromuscul Disord
Journal subject:
NEUROLOGIA
Year:
2022
Type:
Article